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Estrogen Inhibits Calcification of VSMCs via Promotion of
Autophagy
Xiong Dan, Yuan LinQin. The Second XiangYa Hospital, Central
South University, ChangSha, China
Background: Medial artery calcification is an active cell-regulated
process that involves the differentiation of vascular smooth muscle
cells (VSMCs) to an osteoblast-like phenotype. Autophagy is a highly
regulated homoeostatic process involved in the lysosomal degradation
of damaged cell organelles and proteins, which considered an impor-
tant pro-survival mechanism under diverse stress conditions. Arterial
calcification and osteoporosis are both associated in postmenopausal
women. Estrogen is a key therapeutic method for postmenopausal
osteoporosis and is contribute to decrease the coronary-artery calcium
and can promote the autophagy of endothelial cell and VSMC via
EReERKemTOR signaling pathway. But autophagy, as well as the
contribution of estrogen to vascular calcification, is poorly
understood.
Objective: To clarify the effect and the mechanism involved in
estrogen on autophagy and calcification of VSMCs.
Methods: Primary mouse VSMCs were treated with b glycero-
phosphate to induce calcification. Estrogen was incubated with
VSMCs during osteoblatic differentiation. Inhibitors to the following
estrogen receptors were used: estrogen receptor alpha (ERa), estro-
gen receptor beta (ERb), combined ERa and ERb (ERab).3MA or
knock down of ATG5 were selected to block autophagy, rapamycin
(pmTOR) was used to promote autophagy. Runx2 was analyzed by
western blot and ALP activity was measured to study the effect of
estrogen on osteoblastic differentiation. Ultrastructural analysis,
GFP-LC3 redistribution, expression of LC3I/II and ATG5 detected
by western blot were employed to determine the presence of autoph-
agy analysis in VSMCs.
Results: 1. Estrogen reduced the expression of RUNX2 of VSMCs
mainly through ERa but not ERb in the osteogenic medium; 2. Estro-
gen enhanced the autophagy of VSMCs during the process of osteo-
genic differentiation: Estrogen increased the level of the lipid
-conjugate form of the autophagosome marker light-chain 3-II
(LC3II) and ATG5 in VSMCs. Treatment with rampamicin, an
inducer of autophagy, Estrogen further increased the LC3II and
ATG5 level. Estrogen also increased the number of LC3 puncta
tagged with green fluorescent protein (GFP); Electron microscopy
of typical autophagic structures were increased in VSMCs treated
with estrogen. 3. Estrogen inhibited the calcification of VSMC via
enhancing autophagy. Inhibition of autophagy with 3MA or knockingdown ATG5, the expression of RUNX2 was increased compared with
those only treated with estrogen. Furthermore, the expression of
runx2 was further decreased in the VSMCs treated with estrogen
and rampamicin together.
Conclusion: Estrogen inhibits calcification of VSMC via promo-
tion of autophagy through the ERaemTOR signaling pathway.
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Objective: Our previous study demonstrated that ethanol extract of
Lycii Radicis Cortex (LRC) prevented the ovariectomized-induced
bone mineral density loss in mice via promoting the differentiation
of osteoblast linage cells. A single compound, D3G, was isolated
from the LRC extract as a candidate component enhancing bone
formation. The aim of this study was to investigate the antiosteopor-
otic effects of dihydrophaseic acid 3ʹ-O-b-D-glucopyranoside
(D3G).
Methods: The 70% ethanol extract of LRC was evaporated, sus-
pended in H2O, and then partitioned successively with CH2Cl2,
EtOAc, n-BuOH, and aqueous fractions. Fractionation of the LRC
extract was performed to identify the bioactive compound(s) respon-
sible for the bone formation-enhancing effect of LRC extract. The
structure of the isolated compound was elucidated by 1H-NMR,
13C-NMR, and mass spectrometry analyses. To confirm the bioactiv-
ity of the isolated single compound, three different concentrations (1,
5, and 10 mg/ml) of the compound were treated in the osteoblastic cell
lines C3H10T1/2 and MC3T3-E1, and alterations in the ALP activity
of the cells were examined
Results: The highest alkaline phosphatase activity was observed
with 5 mg/ml of D3G in both cell lines: C3H10T1/2 and MC3T3-
E1. The D3G treatment for 21 days increased the mineralized nodule
formation in the MC3T3-E1 cell line. The expression of osteoblastic
markers, Alpl, Runx2, and Bglap, was significantly increased in the
